- call +1-201-465-4211
- email sales@mrinsights.biz
Molecular diagnostics is the application of medical and microbiological technologies to the medical imaging science, in order to analyze biological markers present in the proteome and genome, which also includes the study of how an individual express his/her genes as proteins. The is an important diagnostic and patient monitoring technique, which not only diagnose the disease but also access the risks involved in treatment and suggest suitable therapies for the patients. Nucleic acid test, or nucleic acid amplification test (NAT/NAAT) is another molecular technology used in identification of a bacterium or virus. NAT comprises of all the tests and technologies used to identify genetic material of infecting virus or organism.
Scope of the Report:
This report studies the Molecular Diagnostics and NAT market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Molecular Diagnostics and NAT market by product type and applications/end industries.
At present, the North American region is the most prominent market, owing to extensive diagnostic practices and R&D. However, Asia-Pacific and some countries in RoW region are expected to show very lucrative growth in the upcoming period, owing to enhanced awareness and growth in research and diagnostic technologies.
The global Molecular Diagnostics and NAT market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Molecular Diagnostics and NAT.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Roche
Abbott
BD
Biomerieux
Qiagen
Thermo Fisher Scientific
Agilent
GenMark
Siemens Healthcare
AutoGenomics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Amplification Technologies
Amplified Gene Detection Technologies
DNA And Oligonucleotide Microarrays
Gene Sequencing
Market Segment by Applications, can be divided into
Hospitals and Clinics
Research Institutes
Diagnostic Centers
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Molecular Diagnostics and NAT Market Overview
1.1 Product Overview and Scope of Molecular Diagnostics and NAT
1.2 Classification of Molecular Diagnostics and NAT by Types
1.2.1 Global Molecular Diagnostics and NAT Revenue Comparison by Types (2017-2023)
1.2.2 Global Molecular Diagnostics and NAT Revenue Market Share by Types in 2017
1.2.3 Amplification Technologies
1.2.4 Amplified Gene Detection Technologies
1.2.5 DNA And Oligonucleotide Microarrays
1.2.6 Gene Sequencing
1.3 Global Molecular Diagnostics and NAT Market by Application
1.3.1 Global Molecular Diagnostics and NAT Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals and Clinics
1.3.3 Research Institutes
1.3.4 Diagnostic Centers
1.4 Global Molecular Diagnostics and NAT Market by Regions
1.4.1 Global Molecular Diagnostics and NAT Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Molecular Diagnostics and NAT Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Molecular Diagnostics and NAT Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Molecular Diagnostics and NAT Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Molecular Diagnostics and NAT Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Molecular Diagnostics and NAT Status and Prospect (2013-2023)
1.5 Global Market Size of Molecular Diagnostics and NAT (2013-2023)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Molecular Diagnostics and NAT Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abbott
2.2.1 Business Overview
2.2.2 Molecular Diagnostics and NAT Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abbott Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
2.3 BD
2.3.1 Business Overview
2.3.2 Molecular Diagnostics and NAT Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BD Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
2.4 Biomerieux
2.4.1 Business Overview
2.4.2 Molecular Diagnostics and NAT Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Biomerieux Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
2.5 Qiagen
2.5.1 Business Overview
2.5.2 Molecular Diagnostics and NAT Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Qiagen Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
2.6 Thermo Fisher Scientific
2.6.1 Business Overview
2.6.2 Molecular Diagnostics and NAT Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Thermo Fisher Scientific Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
2.7 Agilent
2.7.1 Business Overview
2.7.2 Molecular Diagnostics and NAT Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Agilent Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
2.8 GenMark
2.8.1 Business Overview
2.8.2 Molecular Diagnostics and NAT Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 GenMark Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
2.9 Siemens Healthcare
2.9.1 Business Overview
2.9.2 Molecular Diagnostics and NAT Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Siemens Healthcare Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
2.10 AutoGenomics
2.10.1 Business Overview
2.10.2 Molecular Diagnostics and NAT Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 AutoGenomics Molecular Diagnostics and NAT Revenue, Gross Margin and Market Share (2016-2017)
3 Global Molecular Diagnostics and NAT Market Competition, by Players
3.1 Global Molecular Diagnostics and NAT Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Molecular Diagnostics and NAT Players Market Share
3.2.2 Top 10 Molecular Diagnostics and NAT Players Market Share
3.3 Market Competition Trend
4 Global Molecular Diagnostics and NAT Market Size by Regions
4.1 Global Molecular Diagnostics and NAT Revenue and Market Share by Regions
4.2 North America Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
4.3 Europe Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
4.5 South America Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
5 North America Molecular Diagnostics and NAT Revenue by Countries
5.1 North America Molecular Diagnostics and NAT Revenue by Countries (2013-2018)
5.2 USA Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
5.3 Canada Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
5.4 Mexico Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
6 Europe Molecular Diagnostics and NAT Revenue by Countries
6.1 Europe Molecular Diagnostics and NAT Revenue by Countries (2013-2018)
6.2 Germany Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
6.3 UK Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
6.4 France Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
6.5 Russia Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
6.6 Italy Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Molecular Diagnostics and NAT Revenue by Countries
7.1 Asia-Pacific Molecular Diagnostics and NAT Revenue by Countries (2013-2018)
7.2 China Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
7.3 Japan Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
7.4 Korea Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
7.5 India Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
8 South America Molecular Diagnostics and NAT Revenue by Countries
8.1 South America Molecular Diagnostics and NAT Revenue by Countries (2013-2018)
8.2 Brazil Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
8.3 Argentina Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
8.4 Colombia Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Molecular Diagnostics and NAT by Countries
9.1 Middle East and Africa Molecular Diagnostics and NAT Revenue by Countries (2013-2018)
9.2 Saudi Arabia Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
9.3 UAE Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
9.4 Egypt Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
9.5 Nigeria Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
9.6 South Africa Molecular Diagnostics and NAT Revenue and Growth Rate (2013-2018)
10 Global Molecular Diagnostics and NAT Market Segment by Type
10.1 Global Molecular Diagnostics and NAT Revenue and Market Share by Type (2013-2018)
10.2 Global Molecular Diagnostics and NAT Market Forecast by Type (2018-2023)
10.3 Amplification Technologies Revenue Growth Rate (2013-2023)
10.4 Amplified Gene Detection Technologies Revenue Growth Rate (2013-2023)
10.5 DNA And Oligonucleotide Microarrays Revenue Growth Rate (2013-2023)
10.6 Gene Sequencing Revenue Growth Rate (2013-2023)
11 Global Molecular Diagnostics and NAT Market Segment by Application
11.1 Global Molecular Diagnostics and NAT Revenue Market Share by Application (2013-2018)
11.2 Molecular Diagnostics and NAT Market Forecast by Application (2018-2023)
11.3 Hospitals and Clinics Revenue Growth (2013-2018)
11.4 Research Institutes Revenue Growth (2013-2018)
11.5 Diagnostic Centers Revenue Growth (2013-2018)
12 Global Molecular Diagnostics and NAT Market Size Forecast (2018-2023)
12.1 Global Molecular Diagnostics and NAT Market Size Forecast (2018-2023)
12.2 Global Molecular Diagnostics and NAT Market Forecast by Regions (2018-2023)
12.3 North America Molecular Diagnostics and NAT Revenue Market Forecast (2018-2023)
12.4 Europe Molecular Diagnostics and NAT Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Molecular Diagnostics and NAT Revenue Market Forecast (2018-2023)
12.6 South America Molecular Diagnostics and NAT Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Molecular Diagnostics and NAT Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Molecular Diagnostics and NAT Picture
Table Product Specifications of Molecular Diagnostics and NAT
Table Global Molecular Diagnostics and NAT and Revenue (Million U
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
